Splicing factors control triple-negative breast cancer cell mitosis through SUN2 interaction and sororin intron retention

Autor: Eline van Steijn, Esmee Koedoot, Marjolein Vermeer, Alfred C.O. Vertegaal, Román González-Prieto, John W.M. Martens, Bob van de Water, Sylvia E. Le Dévédec

Publikováno v: Journal of Experimental & Clinical Cancer Research, 40. Springer Science and Business Media LLC
Journal of Experimental and Clinical Cancer Research, 40(1). BMC
Journal of Experimental & Clinical Cancer Research, 40(1):82. BioMed Central Ltd.
Journal of Experimental & Clinical Cancer Research : CR
Journal of Experimental & Clinical Cancer Research, Vol 40, Iss 1, Pp 1-17 (2021)

Background Triple negative breast cancer (TNBC) is an aggressive subtype of breast cancer with limited therapeutic opportunities. Recently, splicing factors have gained attention as potential targets for cancer treatment. Here we systematically evalu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::738ae893f8d5ab122e39b6a7d3e78fa3
http://hdl.handle.net/1887/3204454